DarioHealth AI Platform Expected to Boost Recurring Revenue by 10-15%

DarioHealth Corp. expects its proprietary AI platform, DarioIQ™, to increase annual B2B2C recurring revenue from existing customers by 10% to 15%. The company anticipates the platform will enhance member engagement and retention within its healthcare services, supporting its business model.

DarioIQ leverages over 13 billion healthcare data points and FDA-cleared devices to deliver personalized care instructions. The platform has demonstrated a 40% increase in member activity and a 20% improvement in retention compared to previous treatments. The company projects further performance improvements as the AI models are enhanced with new data.

According to Lara Dodo, Chief Operating Officer at DarioHealth, higher engagement increases the lifetime value of members and improves customer ROI. This enables revenue growth without a proportionally significant increase in customer acquisition costs.

The company controls the entire care chain, from devices to data and AI. DarioIQ is designed to translate this integrated system into measurable results for patients and payers. DarioHealth is also expanding into provider-backed care, which is expected to increase DarioIQ's long-term value by directly connecting AI-driven engagement with clinical intervention.